Pyrotinib, Trastuzumab And Abraxane in HER2-positive MBC With Brain Metastasis

Cancer shared this article with you from Inoreader Pyrotinib, Trastuzumab And Abraxane in HER2-positive MBC With Brain Metastasis Via MedWorm Cancer & Oncology Clinical Trials Conditions:   Breast Cancer;   HER2-positive Breast Cancer Interventions:   Drug: Pyrotinib Plus And;   Drug: Trastuzumab;   Drug: Abraxane Sponsor:   Shandong Cancer Hospital and Institute Not yet recruiting (Source: ClinicalTrials.gov) MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running. View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.